Tower Records was born in a drugstore. At its height, it had 200 locations and generated $1 billion in revenue in the late 90s. Then, in less than a decade, it was gone.
Breakthroughs in identifying tumor biomarkers in liver, gastric, prostate, lung and other cancers and are accelerating radionuclide therapies.
Health insurer Centene reported first quarter net income of $1.5 billion despite a 2 million enrollee drop in Obamacare enrollment.
Examples of behavioral changes suggest the power of messaging when disseminated from a bully pulpit. Kennedy’s conspicuous visibility reinforces his reach.
Mike Bloomberg announced an additional $350 million commitment towards road safety against what’s been the leading cause of deaths worldwide for 5 to 29 year olds.
This article addresses the emerging use of adjuncts, such as 3D ultrasound, in breast cancer screening.
A large study found specific benefits of a birth doula on maternal and newborn health outcomes.
TrumpRx has signed deals with 86% of the branded drug market. But are prices actually falling for most Americans? A doctor takes a closer look at who benefits and what’s next.
Why fee-for-service and value-based care are failing, and why only a “moonshot” in healthcare payment models can make care affordable again.
Trump’s orders move the U.S. a few steps closer to more widespread research on and use of two sets of controversial yet promising drugs, psychedelic and cannabis products